[go: up one dir, main page]

PL2318026T3 - Kompozycja przeznaczona do kontrolowania wzrostu stężenia glukozy we krwi - Google Patents

Kompozycja przeznaczona do kontrolowania wzrostu stężenia glukozy we krwi

Info

Publication number
PL2318026T3
PL2318026T3 PL09800146T PL09800146T PL2318026T3 PL 2318026 T3 PL2318026 T3 PL 2318026T3 PL 09800146 T PL09800146 T PL 09800146T PL 09800146 T PL09800146 T PL 09800146T PL 2318026 T3 PL2318026 T3 PL 2318026T3
Authority
PL
Poland
Prior art keywords
composition
blood glucose
controlling increase
controlling
increase
Prior art date
Application number
PL09800146T
Other languages
English (en)
Inventor
Dae-Kyu Song
Jinho Lee
Original Assignee
Keimyung Univ Industry Academic Cooperation Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keimyung Univ Industry Academic Cooperation Foundation filed Critical Keimyung Univ Industry Academic Cooperation Foundation
Publication of PL2318026T3 publication Critical patent/PL2318026T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25Synthetic polymers, e.g. vinylic or acrylic polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09800146T 2008-07-23 2009-07-23 Kompozycja przeznaczona do kontrolowania wzrostu stężenia glukozy we krwi PL2318026T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8313508P 2008-07-23 2008-07-23
KR1020090034119A KR100918776B1 (ko) 2009-04-20 2009-04-20 폴리에틸렌 글리콜과 갈레이트 카테킨을 이용한 혈당상승 억제 조성물
PCT/IB2009/053212 WO2010010531A2 (en) 2008-07-23 2009-07-23 Composition for controlling increase in blood glucose
EP09800146.4A EP2318026B1 (en) 2008-07-23 2009-07-23 Composition for controlling increase in blood glucose

Publications (1)

Publication Number Publication Date
PL2318026T3 true PL2318026T3 (pl) 2015-07-31

Family

ID=41356060

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09800146T PL2318026T3 (pl) 2008-07-23 2009-07-23 Kompozycja przeznaczona do kontrolowania wzrostu stężenia glukozy we krwi

Country Status (8)

Country Link
US (2) US20110189316A1 (pl)
EP (1) EP2318026B1 (pl)
JP (1) JP5342644B2 (pl)
KR (1) KR100918776B1 (pl)
CN (1) CN102099047B (pl)
ES (1) ES2539831T3 (pl)
PL (1) PL2318026T3 (pl)
WO (1) WO2010010531A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101155079B1 (ko) * 2011-02-09 2012-06-11 (주) 엔유씨생활과건강 폴리감마글루탐산과 카테킨 갈레이트를 포함하는 혈당상승 억제 및 비만억제 조성물
RU2465912C9 (ru) 2011-10-31 2013-11-20 Закрытое Акционерное Общество "Велес Фарма" Фармацевтическая композиция на основе наномицелл, содержащих эпигаллокатехингаллат, и ее применение для лечения атопического дерматита, болезни крона, аденомиоза и гиперпластических заболеваний предстательной железы
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
EP3050023B1 (en) 2014-10-27 2021-08-25 Aseko, Inc. Subcutaneous outpatient management
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
KR102045814B1 (ko) 2017-11-20 2019-11-18 (주)아모레퍼시픽 다당류 함량이 증진된 녹차 추출물을 유효성분으로 포함하는 조성물
SG11202011698VA (en) 2018-06-05 2020-12-30 Flagship Pioneering Innovations V Inc Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
ES2894177A1 (es) * 2020-08-07 2022-02-11 Univ Rovira I Virgili Composición y método para modular la ingesta de alimentos
KR20240117479A (ko) 2023-01-25 2024-08-01 연세대학교 원주산학협력단 전기자극을 이용한 혈당 조절 능력 개선 장치

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02202581A (ja) * 1989-01-31 1990-08-10 Shiseido Co Ltd 光劣化防止剤
JPH0383929A (ja) * 1989-08-29 1991-04-09 Tsumura & Co 血糖降下剤
JPH04253918A (ja) * 1991-02-05 1992-09-09 Mitsui Norin Kk 血糖上昇抑制剤
KR970011555B1 (ko) * 1993-09-13 1997-07-12 허계성 항혈전제에 유효성분으로 함유되는 녹차 추출물 및 그의 제조방법
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
JP4324335B2 (ja) * 2001-09-07 2009-09-02 花王株式会社 カテキン含有飲料
KR100577677B1 (ko) * 2003-06-25 2006-05-10 (주)현덕비엔티 혈당 강하용 조성물
US20070249545A1 (en) * 2004-08-27 2007-10-25 Rodriguez-Lopez Jose N Dihydrofolate reductase inhibition by epigallocatechin gallate compounds
US20060263453A1 (en) * 2004-11-01 2006-11-23 Thomas Smith Methods and compositions for modulating glutamate dehydrogenase
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
KR20070000573A (ko) * 2005-06-28 2007-01-03 김봉태 혈당저하 및 변비효과가 있는 건강식품 조성물
US20070036874A1 (en) * 2005-08-05 2007-02-15 Litao Zhong Compositions and methods for controlling glucose and lipid uptake from foods
WO2007039262A1 (en) * 2005-09-30 2007-04-12 Dsm Ip Assets B.V. Novel compositions containing polyphenols
WO2009047639A2 (en) * 2007-07-23 2009-04-16 Keimyung University Industry Academic Cooperation Foundation Epicatechin deficient green tea

Also Published As

Publication number Publication date
WO2010010531A2 (en) 2010-01-28
WO2010010531A3 (en) 2010-05-14
EP2318026A2 (en) 2011-05-11
WO2010010531A9 (en) 2010-07-08
US20130052285A1 (en) 2013-02-28
US20110189316A1 (en) 2011-08-04
EP2318026A4 (en) 2012-09-12
EP2318026B1 (en) 2015-03-18
US9180156B2 (en) 2015-11-10
JP2011529041A (ja) 2011-12-01
JP5342644B2 (ja) 2013-11-13
CN102099047B (zh) 2013-07-17
ES2539831T3 (es) 2015-07-06
CN102099047A (zh) 2011-06-15
KR100918776B1 (ko) 2009-09-24

Similar Documents

Publication Publication Date Title
PL2318026T3 (pl) Kompozycja przeznaczona do kontrolowania wzrostu stężenia glukozy we krwi
PT2374452T (pt) Composição de nutrientes
GB0810554D0 (en) Herbicde composition
GB0801119D0 (en) Composition
ZA201102443B (en) Dishwashing composition
GB0809808D0 (en) Composition
TWI348910B (en) Composition for controlling blood glucose and method thereof
GB0801401D0 (en) Composition
PT2341937E (pt) Composição para tratamento de doença
GB0810896D0 (en) Improvements in or relating to sliding supports
IL207593A0 (en) Blood substitute solution
AU325701S (en) Blood reservoir
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
GB0813589D0 (en) Composition
GB0804031D0 (en) Composition
ZA201103771B (en) Hypoallergenic dermatological composition
GB0813165D0 (en) Composition
GB0700578D0 (en) Composition for treating blood conditions
AU2008903843A0 (en) Compounds and methods for blood glucose regulation
GB0816260D0 (en) Biological control composition
AU2009903532A0 (en) Compounds and methods for blood glucose regulation
GB0819960D0 (en) Therapeutic composition
GB0819010D0 (en) Medical uses
GB0809333D0 (en) Medical uses